NIPT Blood Test for Gender: How Early and How Accurate?

NIPT (non-invasive prenatal testing), also called cfDNA screening, is a maternal blood test. During pregnancy, small fragments of fetal DNA (called cell-free fetal DNA) circulate in the mother's bloodstream. A simple blood draw from the mother's arm is all that is needed — the test poses no risk to the baby.

To determine sex, the laboratory looks for Y-chromosome DNA in the sample:

• Y-chromosome DNA present: at least one baby is male.
• Y-chromosome DNA absent: the baby is female (assuming sufficient fetal DNA in the sample).

This is a direct genetic test — it is looking at the baby's actual DNA, not inferring sex from anatomy on a scan. That is why it is more accurate than ultrasound-based methods like nub theory. For the full comparison, see our NIPT vs nub theory guide.

NIPT can typically be done from about 10 weeks of pregnancy. This is because there needs to be enough cell-free fetal DNA in the mother's blood to produce a reliable result. Before about 10 weeks, the concentration of fetal DNA may be too low.

The fetal DNA fraction in maternal blood rises as pregnancy progresses. By 10 weeks, it is typically around 10% of the total cell-free DNA in the sample — enough for a reliable result. Before 7 weeks, the fraction may be insufficient, and results can be unreliable or require a repeat draw.

This makes NIPT the earliest reliable gender prediction method available — earlier than nub theory (which needs a readable scan from about 12 weeks) and far more accurate than old wives' tales or Ramzi theory (which perform at chance regardless of timing).

NIPT is approximately 96–99% accurate for sex determination. The large JAMA meta-analysis by Devaney, Bianchi and colleagues reported a sensitivity of 95.4% and a specificity of 98.6% for detecting Y-chromosome DNA, which translates to roughly 96–99% overall accuracy for sex determination (Devaney et al., JAMA 2011).

Accuracy can be affected by several factors:

• Fetal DNA fraction: if there is not enough fetal DNA in the sample (a "low fetal fraction"), the test may be inconclusive and need repeating.
• Multiple pregnancies: with twins, if Y-chromosome DNA is detected, you know at least one baby is male — but you cannot tell if one or both are boys.
• Maternal factors: in rare cases, the mother may have Y-chromosome DNA in her blood from a previous male pregnancy or from a maternal medical condition, which could produce a false male result.
• Vanishing twin syndrome: if a male twin was present but did not develop, residual Y-chromosome DNA could cause a false male result.

Despite these edge cases, NIPT remains far more accurate than any ultrasound-based method for sex determination.

NIPT is primarily a chromosomal screening test. Its main medical purpose is to screen for chromosomal conditions such as:

• Trisomy 21 (Down's syndrome)
• Trisomy 18 (Edwards' syndrome)
• Trisomy 13 (Patau's syndrome)
• Sex chromosome aneuploidies (such as Turner syndrome and Klinefelter syndrome)

Fetal sex determination is essentially a by-product of the chromosomal analysis — the lab is already looking at the fetal chromosomes, so determining whether Y-chromosome material is present adds no extra cost or effort. Many parents who have NIPT for chromosomal screening are surprised to learn they can also find out the sex — and some laboratories allow you to opt out of receiving the sex information if you prefer not to know.

In the UK, NIPT is available on the NHS in certain circumstances (such as when a combined screening test shows a higher chance of chromosomal conditions), but many parents pay privately for it as an optional screening test.

Private NIPT in the UK typically costs between £200 and £500, depending on the provider and the panel of conditions tested. Results are usually returned in 5–10 working days, as the blood sample must be sent to a laboratory for DNA analysis.

This is where nub theory has a clear advantage for parents who want a quick, low-cost early glimpse: NubHub reads the nub on the 12-week scan you already have for under £40, with results in about 2 hours — a fraction of the cost and time of NIPT. The trade-off is accuracy (roughly 85–90% for nub theory at 12–13 weeks vs 96–99% for NIPT) and the fact that nub theory is an estimate, not a diagnostic test. See our FAQ for details.

They are complementary, not rivals. Here is a head-to-head:

A common, sensible approach: use nub theory for an instant, low-cost glimpse from the 12-week scan, then let NIPT or the 20-week anatomy scan confirm it. When two independent methods agree, you can feel much more confident. See our detailed NIPT vs nub theory comparison, or start with our complete guide to nub theory.

For the 20-week anatomy scan — the clinical standard that confirms sex by viewing the developed genitals directly at ~95–99% accuracy — see our guide on when you can find out the sex.